Its primary mechanism involves the upregulation of T cell-mediated immune killing by targeting co-suppressor molecules, notably programmed death protein-1/programmed death ligand-1 (PD-1/PD-L1), thereby bolstering endogenous host immunity and counteracting tumor immune evasion (37, 38). The gene discussed is CD274; the disease is neoplasm.